Controls (n = 40) | CKD stage 2 (n = 29) | CKD stage 3 (n = 88) | |
LVEF (%) CMR | 71.6 ± 5.9 | 69.9 ± 6.2 | 69.1 ± 8. |
Left ventricular mass index (g/m2) CMR | 55.1 ± 9.4 | 64.2 ± 15.2* | 63.7 ± 12.7† |
LVH (%) | 0 | 9 (36)† | 23 (28)† |
Lateral annular Em (cm/s) | 12.1 ± 3.1 | 10.5 ± 2.4† | 9.0 ± 2.5† |
E/Em | 5.6 ± 1.1 | 7.4 ± 1.8† | 8.0 ± 2.4† |
Colour flow propogation velocity (cm/s) | 62.9 ± 11.0 | 54.6 ± 15.3* | 49.2 ± 14.0† |
LA volumes/BSA (ml/m2) | 19.2 ± 4.0 | 25.2 ± 6.3* | 27.4 ± 6.3† |
Left ventricular Tei Index | 0.38 ± 0.04 | 0.48 ± 0.11† | 0.50 ± 0.12† |
BSA, body surfacr area; CMR, cardiac magnetic resonance; LA, left atrial; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertension.
*p<0.05, †p<0.01 chronic kidney disease (CKD) versus controls.